(Circulation. 1997;96:3180-3191.)
© 1997 American Heart Association, Inc.
Articles |
Inhibitory Role of Plasminogen Activator Inhibitor-1 in Arterial Wound Healing and Neointima Formation
A Gene Targeting and Gene Transfer Study in Mice
From the Center for Transgene Technology and Gene Therapy (P.C., L.M., D.C., R.D.G.), Flanders Interuniversity Institute for Biotechnology, University of Leuven, Leuven, Belgium; Laboratory of Experimental Cardiology (S.J.), University of Leuven, Leuven, Belgium; Vascular Biology Laboratory (F.L.), Thrombosis Research Institute, London, UK; and Department of Biochemistry and Internal Medicine (R.D.G.), University of Texas Southwestern Medical Center, Dallas, Tex.
Correspondence to P. Carmeliet, MD, PhD, Center for Transgene Technology and Gene Therapy, Flanders Interuniversity Institute for Biotechnology, Campus Gasthuisberg, KU Leuven, Herestraat 49, B-3000 Leuven, Belgium.
Background Plasminogen-deficient mice display impaired vascular wound healing and reduced arterial neointima formation after arterial injury, suggesting that inhibition of plasmin generation might reduce arterial neointima formation. Therefore, we studied the consequences of plasminogen activator inhibitor-1 (PAI-1) gene inactivation and adenoviral PAI-1 gene transfer on arterial neointima formation.
Methods and Results Neointima formation was evaluated in PAI-1–deficient (PAI-1-/-) mice with perivascular electric or transluminal mechanical injury. PAI-1 deficiency improved vascular wound healing in both models: the cross-sectional neointimal area was 0.001±0.001 mm2 in PAI-1+/+ and 0.016±0.008 mm2 in PAI-1-/- mice within 1 week after electric injury (P<.02) and 0.055±0.008 mm2 in PAI-1+/+ and 0.126±0.006 mm2 in PAI-1-/- mice within 3 weeks after mechanical injury (P<.001). Proliferation of smooth muscle cells was not affected by PAI-1 deficiency. Topographic analysis of arterial wound healing after electric injury revealed that PAI-1-/- smooth muscle cells, originating from the uninjured borders, more rapidly migrated into the necrotic center of the arterial wound than wild-type smooth muscle cells. On the basis of immunostaining, PAI-1 expression was markedly upregulated during vascular wound healing. There were no genotypic differences in reendothelialization of the vascular wound. When PAI-1-/- mice were intravenously injected with replication- defective adenovirus expressing human PAI-1 (AdCMVPAI-1), plasma PAI-1 antigen levels increased in a dose-dependent fashion up to to 61±8 µg/mL with 2x109 plaque-forming units (pfu) virus. Luminal stenosis was 35±13% in control AdRR5-treated (2x109 pfu) and suppressed to 5±5% in AdCMVPAI-1–treated (6x108 pfu) PAI-1-/- mice (P<.002).
Conclusions By affecting cellular migration, PAI-1 plays an inhibitory role in vascular wound healing and arterial neointima formation after injury, and adenoviral PAI-1 gene transfer reduces arterial neointima formation in mice.
Key Words: plasminogen • angioplasty • stenosis • genetics • viruses
This article has been cited by other articles:
 |
|
 |
|
  W. P. Fay, N. Garg, and M. Sunkar Vascular Functions of the Plasminogen Activation System Arterioscler. Thromb. Vasc. Biol., June 1, 2007; 27(6): 1231 - 1237. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Wang, L. Yin, and M. A. Lazar The Orphan Nuclear Receptor Rev-erb{alpha} Regulates Circadian Expression of Plasminogen Activator Inhibitor Type 1 J. Biol. Chem., November 10, 2006; 281(45): 33842 - 33848. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Chen, R. C. Budd, R. J. Kelm Jr, B. E. Sobel, and D. J. Schneider Augmentation of Proliferation of Vascular Smooth Muscle Cells by Plasminogen Activator Inhibitor Type 1 Arterioscler. Thromb. Vasc. Biol., August 1, 2006; 26(8): 1777 - 1783. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Schafer, M. R. Schroeter, C. Dellas, M. Puls, M. Nitsche, E. Weiss, G. Hasenfuss, and S. V. Konstantinides Plasminogen Activator Inhibitor-1 From Bone Marrow-Derived Cells Suppresses Neointimal Formation After Vascular Injury in Mice Arterioscler. Thromb. Vasc. Biol., June 1, 2006; 26(6): 1254 - 1259. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Otsuka, R. Agah, A. D. Frutkin, T. N. Wight, and D. A. Dichek Transforming Growth Factor Beta 1 Induces Neointima Formation Through Plasminogen Activator Inhibitor-1-Dependent Pathways Arterioscler. Thromb. Vasc. Biol., April 1, 2006; 26(4): 737 - 743. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Dai, K. Viswanathan, Y. M. Sun, X. Li, L. Y. Liu, B. Togonu-Bickersteth, J. Richardson, C. Macaulay, P. Nash, P. Turner, et al. Identification of Myxomaviral Serpin Reactive Site Loop Sequences That Regulate Innate Immune Responses J. Biol. Chem., March 24, 2006; 281(12): 8041 - 8050. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Liang, T. Kanjanabuch, S.-L. Mao, C.-M. Hao, Y.-W. Tang, P. J. Declerck, A. H. Hasty, D. H. Wasserman, A. B. Fogo, and L.-J. Ma Plasminogen activator inhibitor-1 modulates adipocyte differentiation Am J Physiol Endocrinol Metab, January 1, 2006; 290(1): E103 - E113. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Buchwalter, C. Gross, and B. Wasylyk The Ternary Complex Factor Net Regulates Cell Migration through Inhibition of PAI-1 Expression Mol. Cell. Biol., December 15, 2005; 25(24): 10853 - 10862. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Feinbloom and K. A. Bauer Assessment of Hemostatic Risk Factors in Predicting Arterial Thrombotic Events Arterioscler. Thromb. Vasc. Biol., October 1, 2005; 25(10): 2043 - 2053. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Heymans, F. Lupu, S. Terclavers, B. Vanwetswinkel, J.-M. Herbert, A. Baker, D. Collen, P. Carmeliet, and L. Moons Loss or Inhibition of uPA or MMP-9 Attenuates LV Remodeling and Dysfunction after Acute Pressure Overload in Mice Am. J. Pathol., January 1, 2005; 166(1): 15 - 25. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Torzewski, P. Suriyaphol, K. Paprotka, L. Spath, V. Ochsenhirt, A. Schmitt, S.-R. Han, M. Husmann, V. B. Gerl, S. Bhakdi, et al. Enzymatic Modification of Low-Density Lipoprotein in the Arterial Wall: A New Role for Plasmin and Matrix Metalloproteinases in Atherogenesis Arterioscler. Thromb. Vasc. Biol., November 1, 2004; 24(11): 2130 - 2136. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Schneider, M. Hayes, M. Wadsworth, H. Taatjes, M. Rincon, D. J. Taatjes, and B. E. Sobel Attenuation of Neointimal Vascular Smooth Muscle Cellularity in Atheroma by Plasminogen Activator Inhibitor Type 1 (PAI-1) J. Histochem. Cytochem., August 1, 2004; 52(8): 1091 - 1099. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C Roncal, J Orbe, J.A Rodriguez, M Belzunce, O Beloqui, J Diez, and J.A Paramo Influence of the 4G/5G PAI-1 genotype on angiotensin II-stimulated human endothelial cells and in patients with hypertension Cardiovasc Res, July 1, 2004; 63(1): 176 - 185. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. T. Choi, M. F. Khan, J. E. Leidenfrost, E. T. Collins, K. P. Boc, B. R. Villa, D. V. Novack, W. C. Parks, and D. R. Abendschein {beta}3-Integrin Mediates Smooth Muscle Cell Accumulation in Neointima After Carotid Ligation in Mice Circulation, March 30, 2004; 109(12): 1564 - 1569. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. E. Sobel, D. J. Taatjes, and D. J. Schneider Intramural Plasminogen Activator Inhibitor Type-1 and Coronary Atherosclerosis Arterioscler. Thromb. Vasc. Biol., November 1, 2003; 23(11): 1979 - 1989. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Lambert, C. Munaut, P. Carmeliet, R. D. Gerard, P. J. Declerck, A. Gils, C. Claes, J.-M. Foidart, A. Noel, and J.-M. Rakic Dose-Dependent Modulation of Choroidal Neovascularization by Plasminogen Activator Inhibitor Type I: Implications for Clinical Trials Invest. Ophthalmol. Vis. Sci., June 1, 2003; 44(6): 2791 - 2797. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Dai, H. Guan, L. Liu, S. Little, G. McFadden, S. Vaziri, H. Cao, I. A. Ivanova, L. Bocksch, and A. Lucas Serp-1, a Viral Anti-inflammatory Serpin, Regulates Cellular Serine Proteinase and Serpin Responses to Vascular Injury J. Biol. Chem., May 9, 2003; 278(20): 18563 - 18572. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Konstantinides, K. Schafer, and D. J. Loskutoff Do PAI-1 and Vitronectin Promote or Inhibit Neointima Formation?: The Exact Role of the Fibrinolytic System in Vascular Remodeling Remains Uncertain Arterioscler. Thromb. Vasc. Biol., December 1, 2002; 22(12): 1943 - 1945. [Full Text] [PDF]
|
|
|
|
|
|
V. de Waard, E. K. Arkenbout, P. Carmeliet, V. Lindner, and H. Pannekoek Plasminogen Activator Inhibitor 1 and Vitronectin Protect Against Stenosis in a Murine Carotid Artery Ligation Model Arterioscler. Thromb. Vasc. Biol., December 1, 2002; 22(12): 1978 - 1983. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Bass, A.-M. M. Fernandez, and V. Ellis Maspin Inhibits Cell Migration in the Absence of Protease Inhibitory Activity J. Biol. Chem., November 27, 2002; 277(49): 46845 - 46848. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.L.M. Lamfers, J.M. Grimbergen, M.C. Aalders, M.J. Havenga, M.R. de Vries, L.G.M. Huisman, V.W.M. van Hinsbergh, and P.H.A. Quax Gene Transfer of the Urokinase-Type Plasminogen Activator Receptor-Targeted Matrix Metalloproteinase Inhibitor TIMP-1.ATF Suppresses Neointima Formation More Efficiently Than Tissue Inhibitor of Metalloproteinase-1 Circ. Res., November 15, 2002; 91(10): 945 - 952. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Vaughan PAI-1 and Cellular Migration: Dabbling in Paradox Arterioscler. Thromb. Vasc. Biol., October 1, 2002; 22(10): 1522 - 1523. [Full Text] [PDF]
|
|
|
|
|
|
S. Tanaka, H. Koyama, T. Ichii, A. Shioi, M. Hosoi, E. W. Raines, and Y. Nishizawa Fibrillar Collagen Regulation of Plasminogen Activator Inhibitor-1 Is Involved in Altered Smooth Muscle Cell Migration Arterioscler. Thromb. Vasc. Biol., October 1, 2002; 22(10): 1573 - 1578. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Peng, N. Bhatia, A. C. Parker, Y. Zhu, and W. P. Fay Endogenous Vitronectin and Plasminogen Activator Inhibitor-1 Promote Neointima Formation in Murine Carotid Arteries Arterioscler. Thromb. Vasc. Biol., June 1, 2002; 22(6): 934 - 939. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G. Kuhel, B. Zhu, D. P. Witte, and D. Y. Hui Distinction in Genetic Determinants for Injury-Induced Neointimal Hyperplasia and Diet-Induced Atherosclerosis in Inbred Mice Arterioscler. Thromb. Vasc. Biol., June 1, 2002; 22(6): 955 - 960. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. R. Binder, G. Christ, F. Gruber, N. Grubic, P. Hufnagl, M. Krebs, J. Mihaly, and G. W. Prager Plasminogen Activator Inhibitor 1: Physiological and Pathophysiological Roles Physiology, April 1, 2002; 17(2): 56 - 61. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. W. Rijneveld, M. Levi, S. Florquin, P. Speelman, P. Carmeliet, and T. van der Poll Urokinase Receptor Is Necessary for Adequate Host Defense Against Pneumococcal Pneumonia J. Immunol., April 1, 2002; 168(7): 3507 - 3511. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. DEVY, S. BLACHER, C. GRIGNET-DEBRUS, K. BAJOU, V. MASSON, R. D. GERARD, A. GILS, G. CARMELIET, P. CARMELIET, P. J. DECLERCK, et al. The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent FASEB J, February 1, 2002; 16(2): 147 - 154. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C.Y. Chan, D. A. Duszczyszyn, F. J. Castellino, and V. A. Ploplis Accelerated Skin Wound Healing in Plasminogen Activator Inhibitor-1-Deficient Mice Am. J. Pathol., November 1, 2001; 159(5): 1681 - 1688. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. DeYoung, C. Tom, and D. A. Dichek Plasminogen Activator Inhibitor Type 1 Increases Neointima Formation in Balloon-Injured Rat Carotid Arteries Circulation, October 16, 2001; 104(16): 1972 - 1971. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Vermeersch, Z. Nong, E. Stabile, O. Varenne, H. Gillijns, M. Pellens, N. Van Pelt, M. Hoylaerts, I. De Scheerder, D. Collen, et al. L-Arginine Administration Reduces Neointima Formation After Stent Injury in Rats by a Nitric Oxide-Mediated Mechanism Arterioscler. Thromb. Vasc. Biol., October 1, 2001; 21(10): 1604 - 1609. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Zhu, P. M. Farrehi, and W. P. Fay Plasminogen Activator Inhibitor Type 1 Enhances Neointima Formation After Oxidative Vascular Injury in Atherosclerosis-Prone Mice Circulation, June 26, 2001; 103(25): 3105 - 3110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Patterson, G. A. Stouffer, N. Madamanchi, and M. S. Runge New Tricks for Old Dogs : Nonthrombotic Effects of Thrombin in Vessel Wall Biology Circ. Res., May 25, 2001; 88(10): 987 - 997. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. LAMBERT, C. MUNAUT, A. NOEL, F. FRANKENNE, K. BAJOU, R. GERARD, P. CARMELIET, M. P. DEFRESNE, J.-M. FOIDART, and J.-M. RAKIC Influence of plasminogen activator inhibitor type 1 on choroidal neovascularization FASEB J, April 1, 2001; 15(6): 1021 - 1027. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Bajou, V. Masson, R. D. Gerard, P. M. Schmitt, V. Albert, M. Praus, L. R. Lund, T. L. Frandsen, N. Brunner, K. Dano, et al. The Plasminogen Activator Inhibitor PAI-1 Controls In Vivo Tumor Vascularization by Interaction with Proteases, Not Vitronectin: Implications for Antiangiogenic Strategies J. Cell Biol., February 20, 2001; 152(4): 777 - 784. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Orbe, J. A Rodriguez, A. Calvo, A. Grau, M. S Belzunce, D. Martinez-Caro, and J. A Paramo Vitamins C and E attenuate plasminogen activator inhibitor-1 (PAI-1) expression in a hypercholesterolemic porcine model of angioplasty Cardiovasc Res, February 1, 2001; 49(2): 484 - 492. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. H. A. Quax, M. L. M. Lamfers, J. H. P. Lardenoye, J. M. Grimbergen, M. R. de Vries, J. Slomp, M. C. de Ruiter, M. M. Kockx, J. H. Verheijen, and V. W. M. van Hinsbergh Adenoviral Expression of a Urokinase Receptor-Targeted Protease Inhibitor Inhibits Neointima Formation in Murine and Human Blood Vessels Circulation, January 30, 2001; 103(4): 562 - 569. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Konstantinides, K. Schafer, T. Thinnes, and D. J. Loskutoff Plasminogen Activator Inhibitor-1 and Its Cofactor Vitronectin Stabilize Arterial Thrombi After Vascular Injury in Mice Circulation, January 30, 2001; 103(4): 576 - 583. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Redmond, J. P. Cullen, P. A. Cahill, J. V. Sitzmann, S. Stefansson, D. A. Lawrence, and S. S. Okada Endothelial Cells Inhibit Flow-Induced Smooth Muscle Cell Migration : Role of Plasminogen Activator Inhibitor-1 Circulation, January 30, 2001; 103(4): 597 - 603. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. A. Ploplis, I. Cornelissen, M. J. Sandoval-Cooper, L. Weeks, F. A. Noria, and F. J. Castellino Remodeling of the Vessel Wall after Copper-Induced Injury Is Highly Attenuated in Mice with a Total Deficiency of Plasminogen Activator Inhibitor-1 Am. J. Pathol., January 1, 2001; 158(1): 107 - 117. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. T. Eitzman, R. J. Westrick, Z. Xu, J. Tyson, and D. Ginsburg Plasminogen activator inhibitor-1 deficiency protects against atherosclerosis progression in the mouse carotid artery Blood, December 15, 2000; 96(13): 4212 - 4215. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. P. Kohler and P. J. Grant Plasminogen-Activator Inhibitor Type 1 and Coronary Artery Disease N. Engl. J. Med., June 15, 2000; 342(24): 1792 - 1801. [Full Text] [PDF]
|
|
|
|
|
|
H. R. Lijnen, B. Van Hoef, M. Dewerchin, and D. Collen {alpha}2-Antiplasmin Gene Deficiency in Mice Does Not Affect Neointima Formation After Vascular Injury Arterioscler. Thromb. Vasc. Biol., June 1, 2000; 20(6): 1488 - 1492. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Stoop, F. Lupu, and H. Pannekoek Colocalization of Thrombin, PAI-1, and Vitronectin in the Atherosclerotic Vessel Wall : A Potential Regulatory Mechanism of Thrombin Activity by PAI-1/Vitronectin Complexes Arterioscler. Thromb. Vasc. Biol., April 1, 2000; 20(4): 1143 - 1149. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Koziczak, W. Krek, and Y. Nagamine Pocket Protein-Independent Repression of Urokinase-Type Plasminogen Activator and Plasminogen Activator Inhibitor 1 Gene Expression by E2F1 Mol. Cell. Biol., March 15, 2000; 20(6): 2014 - 2022. [Abstract] [Full Text]
|
|
|
|
|
|
D. Hasenstab, H. Lea, and A. W. Clowes Local Plasminogen Activator Inhibitor Type 1 Overexpression in Rat Carotid Artery Enhances Thrombosis and Endothelial Regeneration While Inhibiting Intimal Thickening Arterioscler. Thromb. Vasc. Biol., March 1, 2000; 20(3): 853 - 859. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Lopez, F. Peiretti, B. Bonardo, I. Juhan-Vague, and G. Nalbone Tumor Necrosis Factor alpha Up-regulates in an Autocrine Manner the Synthesis of Plasminogen Activator Inhibitor Type-1 during Induction of Monocytic Differentiation of Human HL-60 Leukemia Cells J. Biol. Chem., February 4, 2000; 275(5): 3081 - 3087. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Dichtl, A. Stiko, P. Eriksson, I. Goncalves, F. Calara, C. Banfi, M. P. S. Ares, A. Hamsten, and J. Nilsson Oxidized LDL and Lysophosphatidylcholine Stimulate Plasminogen Activator Inhibitor-1 Expression in Vascular Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., December 1, 1999; 19(12): 3025 - 3032. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. H. Strauss, H. K. Lau, K. A. Bowman, J. Sparkes, R. J. Chisholm, M. B. Garvey, L. L. Fenkell, M. K. Natarajan, I. Singh, and J. M. Teitel Plasma Urokinase Antigen and Plasminogen Activator Inhibitor-1 Antigen Levels Predict Angiographic Coronary Restenosis Circulation, October 12, 1999; 100(15): 1616 - 1622. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Rosnoblet, U. M. Vischer, R. D. Gerard, J.-C. Irminger, P. A. Halban, and E. K. O. Kruithof Storage of Tissue-Type Plasminogen Activator in Weibel-Palade Bodies of Human Endothelial Cells Arterioscler. Thromb. Vasc. Biol., July 1, 1999; 19(7): 1796 - 1803. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Cesari and G. P. Rossi Plasminogen Activator Inhibitor Type 1 in Ischemic Cardiomyopathy Arterioscler. Thromb. Vasc. Biol., June 1, 1999; 19(6): 1378 - 1386. [Full Text] [PDF]
|
|
|
|
|
|
B. E. Sobel Increased Plasminogen Activator Inhibitor-1 and Vasculopathy : A Reconcilable Paradox Circulation, May 18, 1999; 99(19): 2496 - 2498. [Full Text] [PDF]
|
|
|
|
|
|
N. Nagai, M. De Mol, H. R. Lijnen, P. Carmeliet, and D. Collen Role of Plasminogen System Components in Focal Cerebral Ischemic Infarction : A Gene Targeting and Gene Transfer Study in Mice Circulation, May 11, 1999; 99(18): 2440 - 2444. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C Newby and A. B Zaltsman Fibrous cap formation or destruction -- the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation Cardiovasc Res, February 1, 1999; 41(2): 345 - 360. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Bouchie, H. Hansen, and E. P. Feener Natriuretic Factors and Nitric Oxide Suppress Plasminogen Activator Inhibitor-1 Expression in Vascular Smooth Muscle Cells : Role of cGMP in the Regulation of the Plasminogen System Arterioscler. Thromb. Vasc. Biol., November 1, 1998; 18(11): 1771 - 1779. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Carmeliet, L. Moons, and D. Collen Mouse models of angiogenesis, arterial stenosis, atherosclerosis and hemostasis Cardiovasc Res, July 1, 1998; 39(1): 8 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
|